Locally based real estate investment firm BioMed Realty Trust Inc. saw revenue rise 23.9 percent for its fourth quarter ending Dec. 31, and 18.3 percent for the full year 2012.

A company statement said the San Diego-based real estate investment trust posted total revenue of $138.8 million for the quarter and $518.2 million for the year.

The company reported a 2012 net loss attributable to common stockholders of $2.8 million, compared with net income of $26 million in 2011. The net loss for the year included acquisition-related expenses of $13.1 million.

Officials reported that funds from operations, a supplemental industry-recognized metric gauging the performance of real estate portfolios, rose 27 percent for the quarter, to $59.5 million. For the full year, funds from operations increased 18 percent, to $206.5 million.

BioMed focuses on life sciences real estate and trades under the symbol BMR on the New York Stock Exchange.

— SDBJ Staff Report